Teleflex Inc (TFX)
208.49
-2.72
(-1.29%)
USD |
NYSE |
Nov 04, 13:04
Teleflex Enterprise Value: 11.32B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 11.32B |
| October 31, 2024 | 10.85B |
| October 30, 2024 | 12.44B |
| October 29, 2024 | 12.50B |
| October 28, 2024 | 12.51B |
| October 25, 2024 | 12.37B |
| October 24, 2024 | 12.46B |
| October 23, 2024 | 12.56B |
| October 22, 2024 | 12.51B |
| October 21, 2024 | 12.50B |
| October 18, 2024 | 12.66B |
| October 17, 2024 | 12.39B |
| October 16, 2024 | 12.44B |
| October 15, 2024 | 12.45B |
| October 14, 2024 | 12.54B |
| October 11, 2024 | 12.48B |
| October 10, 2024 | 12.41B |
| October 09, 2024 | 12.40B |
| October 08, 2024 | 12.43B |
| October 07, 2024 | 12.33B |
| October 04, 2024 | 12.62B |
| October 03, 2024 | 12.64B |
| October 02, 2024 | 12.84B |
| October 01, 2024 | 12.90B |
| September 30, 2024 | 13.00B |
| Date | Value |
|---|---|
| September 27, 2024 | 13.11B |
| September 26, 2024 | 13.02B |
| September 25, 2024 | 13.02B |
| September 24, 2024 | 13.07B |
| September 23, 2024 | 13.02B |
| September 20, 2024 | 12.91B |
| September 19, 2024 | 13.06B |
| September 18, 2024 | 12.86B |
| September 17, 2024 | 12.86B |
| September 16, 2024 | 13.07B |
| September 13, 2024 | 13.07B |
| September 12, 2024 | 12.92B |
| September 11, 2024 | 13.00B |
| September 10, 2024 | 13.11B |
| September 09, 2024 | 13.03B |
| September 06, 2024 | 13.00B |
| September 05, 2024 | 12.94B |
| September 04, 2024 | 13.02B |
| September 03, 2024 | 13.02B |
| August 30, 2024 | 13.03B |
| August 29, 2024 | 12.95B |
| August 28, 2024 | 12.88B |
| August 27, 2024 | 12.87B |
| August 26, 2024 | 12.87B |
| August 23, 2024 | 12.90B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.586B
Minimum
Oct 27 2023
22.80B
Maximum
Apr 28 2021
15.58B
Average
14.72B
Median
Mar 16 2020
Enterprise Value Benchmarks
| Boston Scientific Corp | 131.03B |
| Haemonetics Corp | 4.537B |
| Globus Medical Inc | 10.08B |
| Edwards Lifesciences Corp | 39.36B |
| Halozyme Therapeutics Inc | 8.109B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 111.00M |
| Revenue (Quarterly) | 764.38M |
| Total Expenses (Quarterly) | 620.19M |
| EPS Diluted (Quarterly) | 2.36 |
| Gross Profit Margin (Quarterly) | 56.28% |
| Profit Margin (Quarterly) | 14.52% |
| Earnings Yield | 2.41% |
| Operating Earnings Yield | 4.08% |
| Normalized Earnings Yield | 2.880 |